Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 307

1.

Draft Genome Sequence of Mycobacterium montefiorense Isolated from Japanese Black Salamander (Hynobius nigrescens).

Fukano H, Yoshida M, Shimizu A, Iwao H, Katayama Y, Omatsu T, Mizutani T, Kurata O, Wada S, Hoshino Y.

Genome Announc. 2018 May 24;6(21). pii: e00448-18. doi: 10.1128/genomeA.00448-18.

2.

Red ginseng extracts attenuate skin inflammation in atopic dermatitis through p70 ribosomal protein S6 kinase activation.

Osada-Oka M, Hirai S, Izumi Y, Misumi K, Samukawa K, Tomita S, Miura K, Minamiyama Y, Iwao H.

J Pharmacol Sci. 2018 Jan;136(1):9-15. doi: 10.1016/j.jphs.2017.11.002. Epub 2017 Nov 10.

3.

Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells.

Kita K, Shiota M, Tanaka M, Otsuka A, Matsumoto M, Kato M, Tamada S, Iwao H, Miura K, Nakatani T, Tomita S.

Cancer Sci. 2017 Sep;108(9):1820-1827. doi: 10.1111/cas.13318. Epub 2017 Aug 12.

4.

Macrophage-derived exosomes induce inflammatory factors in endothelial cells under hypertensive conditions.

Osada-Oka M, Shiota M, Izumi Y, Nishiyama M, Tanaka M, Yamaguchi T, Sakurai E, Miura K, Iwao H.

Hypertens Res. 2017 Apr;40(4):353-360. doi: 10.1038/hr.2016.163. Epub 2016 Nov 24.

PMID:
27881852
5.

Simultaneous spawning by female stream goby Rhinogobius sp. and the association with brood cannibalism by nesting males.

Ito S, Iwao H, Sakata J, Inoue M, Omori K, Yanagisawa Y.

J Fish Biol. 2016 Sep;89(3):1592-602. doi: 10.1111/jfb.13060. Epub 2016 Jun 20.

PMID:
27325563
6.

Corrigendum: Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.

Yoshida K, Kim-Mitsuyama S, Wake R, Izumiya Y, Izumi Y, Yukimura T, Ueda M, Yoshiyama M, Iwao H.

Hypertens Res. 2016 Jun;39(6):482. doi: 10.1038/hr.2016.33. No abstract available.

PMID:
27264876
7.

Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells.

Takahashi K, Tanaka M, Yashiro M, Matsumoto M, Ohtsuka A, Nakayama KI, Izumi Y, Nagayama K, Miura K, Iwao H, Shiota M.

Cancer Lett. 2016 Aug 1;378(1):8-15. doi: 10.1016/j.canlet.2016.05.002. Epub 2016 May 6.

PMID:
27157913
8.

Isolation of vascular smooth muscle antigen-reactive CD4(+)αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice.

Fujita Y, Fujii T, Shimizu H, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H, Mimori T.

Cell Immunol. 2016 May;303:50-4. doi: 10.1016/j.cellimm.2016.03.004. Epub 2016 Mar 21.

PMID:
27019130
9.

Identification of low-abundance proteins in serum via the isolation of HSP72 complexes.

Tanaka M, Shiota M, Nakao T, Uemura R, Nishi S, Ohkawa Y, Matsumoto M, Yamaguchi M, Osada-Oka M, Inagaki A, Takahashi K, Nakayama KI, Gi M, Izumi Y, Miura K, Iwao H.

J Proteomics. 2016 Mar 16;136:214-21. doi: 10.1016/j.jprot.2016.01.008. Epub 2016 Jan 15.

PMID:
26780229
10.

Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats.

Yamaguchi T, Izumi Y, Yamazaki T, Nakamura Y, Sano S, Shiota M, Miura K, Iwao H, Yoshiyama M.

Osaka City Med J. 2015 Jun;61(1):31-41.

PMID:
26434103
11.

Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.

Sakai T, Masaki Y, Otsuki N, Sakamaki I, Kishi S, Miyazono T, Urasaki Y, Murakami J, Satoh T, Nakamura T, Iwao H, Nakajima A, Kawanami T, Miki M, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Ueda T.

Med Oncol. 2015 Sep;32(9):232. doi: 10.1007/s12032-015-0677-9. Epub 2015 Aug 15.

12.

Thymic lymphoid hyperplasia with multilocular thymic cysts diagnosed before the Sjögren syndrome diagnosis.

Minato H, Kinoshita E, Nakada S, Nojima T, Tanaka M, Usuda K, Sagawa M, Iwao H, Tanaka M, Doai M, Takahashi T, Shibata N.

Diagn Pathol. 2015 Jul 16;10:103. doi: 10.1186/s13000-015-0332-y.

13.

Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.

Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K, Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.

PLoS One. 2015 May 14;10(5):e0126582. doi: 10.1371/journal.pone.0126582. eCollection 2015.

14.

Nitric oxide modulation of endothelium-derived hyperpolarizing factor in agonist-induced depressor responses in anesthetized rats.

Kobuchi S, Miura K, Iwao H, Ayajiki K.

Eur J Pharmacol. 2015 Sep 5;762:26-34. doi: 10.1016/j.ejphar.2015.04.053. Epub 2015 May 8.

PMID:
25962662
15.

Percutaneous carbon dioxide mist treatment has protective effects in experimental myocardial infarction.

Yamaguchi T, Yamazaki T, Nakamura Y, Shiota M, Shimada K, Miura K, Iwao H, Yoshiyama M, Izumi Y.

J Pharmacol Sci. 2015 Apr;127(4):474-80. doi: 10.1016/j.jphs.2015.03.009. Epub 2015 Apr 1.

16.

Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction.

Yamaguchi T, Izumi Y, Nakamura Y, Yamazaki T, Shiota M, Sano S, Tanaka M, Osada-Oka M, Shimada K, Miura K, Yoshiyama M, Iwao H.

Int J Cardiol. 2015 Jan 15;178:239-46. doi: 10.1016/j.ijcard.2014.10.144. Epub 2014 Oct 30.

PMID:
25464262
17.

Noninvasive metabolic syndrome model using an extremely small minipig, the microminipig.

Yamaguchi T, Yamazaki T, Kawaguchi H, Tawa M, Nakamura Y, Shiota M, Osada-Oka M, Tanimoto A, Okamura T, Miura K, Iwao H, Yoshiyama M, Izumi Y.

J Pharmacol Sci. 2014;126(2):168-71. Epub 2014 Sep 19.

18.

Establishment of neutralizing rat monoclonal antibodies for fibroblast growth factor-2.

Tanaka M, Yamaguchi M, Shiota M, Kawamoto Y, Takahashi K, Inagaki A, Osada-Oka M, Harada A, Wanibuchi H, Izumi Y, Miura K, Iwao H, Ohkawa Y.

Monoclon Antib Immunodiagn Immunother. 2014 Aug;33(4):261-9. doi: 10.1089/mab.2013.0085.

19.

Percutaneous carbon dioxide treatment using a gas mist generator enhances the collateral blood flow in the ischemic hindlimb.

Izumi Y, Yamaguchi T, Yamazaki T, Yamashita N, Nakamura Y, Shiota M, Tanaka M, Sano S, Osada-Oka M, Shimada K, Wanibuchi H, Miura K, Yoshiyama M, Iwao H.

J Atheroscler Thromb. 2015;22(1):38-51. doi: 10.5551/jat.23770. Epub 2014 Aug 15.

20.

Hsc70 contributes to cancer cell survival by preventing Rab1A degradation under stress conditions.

Tanaka M, Mun S, Harada A, Ohkawa Y, Inagaki A, Sano S, Takahashi K, Izumi Y, Osada-Oka M, Wanibuchi H, Yamagata M, Yukimura T, Miura K, Shiota M, Iwao H.

PLoS One. 2014 May 6;9(5):e96785. doi: 10.1371/journal.pone.0096785. eCollection 2014.

21.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).

Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension.

Hypertens Res. 2014 Apr;37(4):253-390. doi: 10.1038/hr.2014.20. No abstract available.

PMID:
24705419
22.

Lipid synthesis is promoted by hypoxic adipocyte-derived exosomes in 3T3-L1 cells.

Sano S, Izumi Y, Yamaguchi T, Yamazaki T, Tanaka M, Shiota M, Osada-Oka M, Nakamura Y, Wei M, Wanibuchi H, Iwao H, Yoshiyama M.

Biochem Biophys Res Commun. 2014 Mar 7;445(2):327-33. doi: 10.1016/j.bbrc.2014.01.183. Epub 2014 Feb 7.

PMID:
24513287
23.

Therapeutic potential of vasopressin-receptor antagonists in heart failure.

Izumi Y, Miura K, Iwao H.

J Pharmacol Sci. 2014;124(1):1-6. Epub 2014 Jan 7. Review.

24.

Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.

Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H.

J Immunol. 2014 Feb 1;192(3):979-84. doi: 10.4049/jimmunol.1301685. Epub 2014 Jan 3.

25.

Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line.

Takahashi K, Tanaka M, Inagaki A, Wanibuchi H, Izumi Y, Miura K, Nagayama K, Shiota M, Iwao H.

Int J Oncol. 2013 Dec;43(6):1985-91. doi: 10.3892/ijo.2013.2135. Epub 2013 Oct 10.

PMID:
24126575
26.

Tolvaptan attenuates left ventricular fibrosis after acute myocardial infarction in rats.

Yamazaki T, Nakamura Y, Shiota M, Osada-Oka M, Fujiki H, Hanatani A, Shimada K, Miura K, Yoshiyama M, Iwao H, Izumi Y.

J Pharmacol Sci. 2013 Sep 20;123(1):58-66. Epub 2013 Sep 3.

27.

Comparative Genomic Analysis of Acheta domesticus Densovirus Isolates from Different Outbreaks in Europe, North America, and Japan.

Pham HT, Iwao H, Szelei J, Li Y, Liu K, Bergoin M, Tijssen P.

Genome Announc. 2013 Aug 15;1(4). pii: e00629-13. doi: 10.1128/genomeA.00629-13.

28.

Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.

J Clin Exp Hematop. 2013;53(1):79-85.

29.

New Volvovirus Isolates from Acheta domesticus (Japan) and Gryllus assimilis (United States).

Pham HT, Iwao H, Bergoin M, Tijssen P.

Genome Announc. 2013 Jun 27;1(3). pii: e00328-13. doi: 10.1128/genomeA.00328-13.

30.

Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.

Fukushima T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Okazaki T, Nakajima H, Motoo Y, Umehara H.

Anticancer Res. 2012 Dec;32(12):5437-40.

PMID:
23225448
31.

Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndrome.

Kawanami T, Sawaki T, Sakai T, Miki M, Iwao H, Nakajima A, Nakamura T, Sato T, Fujita Y, Tanaka M, Masaki Y, Fukushima T, Hirose Y, Taniguchi M, Sugimoto N, Okazaki T, Umehara H.

PLoS One. 2012;7(10):e45689. doi: 10.1371/journal.pone.0045689. Epub 2012 Oct 30.

32.

Tolvaptan improves left ventricular dysfunction after myocardial infarction in rats.

Yamazaki T, Izumi Y, Nakamura Y, Yamashita N, Fujiki H, Osada-Oka M, Shiota M, Hanatani A, Shimada K, Iwao H, Yoshiyama M.

Circ Heart Fail. 2012 Nov;5(6):794-802. doi: 10.1161/CIRCHEARTFAILURE.112.968750. Epub 2012 Sep 14.

PMID:
22984091
33.

Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.

Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, Nakada S, Matsui S, Origuchi T, Nishiyama S, Yamada K, Kawano M, Hirabayashi A, Fujikawa K, Sugiura T, Horikoshi M, Umeda N, Minato H, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Eguchi K, Sugai S, Umehara H.

Int J Rheumatol. 2012;2012:580814. doi: 10.1155/2012/580814. Epub 2012 May 10.

34.

[Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report].

Fukushima T, Iwao H, Sakai T, Sato T, Nakamura T, Nakajima A, Miki M, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Umehara H.

Gan To Kagaku Ryoho. 2012 May;39(5):805-7. Japanese.

PMID:
22584336
35.

Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.

Fukushima T, Kawabata H, Sawaki T, Satoh T, Nakamura T, Iwao H, Nakajima A, Sakai T, Miki M, Fujita Y, Tanaka M, Kawanami T, Masaki Y, Okazaki T, Umehara H.

Anticancer Res. 2012 Apr;32(4):1347-53.

PMID:
22493369
36.

Red ginseng inhibits scratching behavior associated with atopic dermatitis in experimental animal models.

Samukawa K, Izumi Y, Shiota M, Nakao T, Osada-Oka M, Miura K, Iwao H.

J Pharmacol Sci. 2012;118(3):391-400. Epub 2012 Mar 2.

37.

Novel device that produces carbon dioxide mist for myocardial infarction treatment in rats.

Yamazaki T, Izumi Y, Nakamura Y, Hanatani A, Shimada K, Muro T, Shiota M, Iwao H, Yoshiyama M.

Circ J. 2012;76(5):1203-12. Epub 2012 Feb 23.

38.

CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice.

Dong L, Watanabe K, Itoh M, Huan CR, Tong XP, Nakamura T, Miki M, Iwao H, Nakajima A, Sakai T, Kawanami T, Sawaki T, Masaki Y, Fukushima T, Fujita Y, Tanaka M, Yano M, Okazaki T, Umehara H.

Int Immunol. 2012 May;24(5):327-37. doi: 10.1093/intimm/dxs008. Epub 2012 Feb 17.

PMID:
22345277
39.

Angiotensin AT1 receptor blockers suppress oxidized low-density lipoprotein-derived formation of foam cells.

Osada-Oka M, Kita H, Yagi S, Sato T, Izumi Y, Iwao H.

Eur J Pharmacol. 2012 Mar 15;679(1-3):9-15. doi: 10.1016/j.ejphar.2011.12.044. Epub 2012 Jan 16.

PMID:
22265725
40.

Pravastatin-induced proangiogenic effects depend upon extracellular FGF-2.

Shiota M, Hikita Y, Kawamoto Y, Kusakabe H, Tanaka M, Izumi Y, Nakao T, Miura K, Funae Y, Iwao H.

J Cell Mol Med. 2012 Sep;16(9):2001-9. doi: 10.1111/j.1582-4934.2011.01494.x.

41.

The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.

Yamazaki T, Yamashita N, Izumi Y, Nakamura Y, Shiota M, Hanatani A, Shimada K, Muro T, Iwao H, Yoshiyama M.

Hypertens Res. 2012 Jan;35(1):34-40. doi: 10.1038/hr.2011.139. Epub 2011 Aug 25.

PMID:
21866107
42.

Generation of a rat monoclonal antibody specific for hsp72.

Tanaka M, Shiota M, Okada S, Harada A, Odawara J, Mun S, Iwao H, Ohkawa Y.

Hybridoma (Larchmt). 2011 Aug;30(4):397-400. doi: 10.1089/hyb.2011.0015.

PMID:
21851242
43.

[A case of Castleman disease with status epileptics originating from focal cortical dysplasia].

Kaito M, Iwao H, Kinoshita E, Funaki H, Tachibana O, Matsui M.

Rinsho Shinkeigaku. 2011 Jul;51(7):487-92. Japanese.

PMID:
21823508
44.

Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.

Fukushima T, Nakamura T, Iwao H, Umehara H.

Am J Hematol. 2011 Oct;86(10):893. doi: 10.1002/ajh.22110. Epub 2011 Aug 2. No abstract available.

45.

Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events.

Fukushima T, Nakamura T, Iwao H, Nakajima A, Miki M, Sato T, Sakai T, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Nakajima H, Motoo Y, Umehara H.

Anticancer Res. 2011 Jun;31(6):2297-302.

PMID:
21737655
46.

Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.

Fukushima T, Kawabata H, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Hirose Y, Umehara H.

Anticancer Res. 2011 May;31(5):1741-4.

PMID:
21617233
47.

High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma.

Masaki Y, Miki M, Sun Y, Nakamura T, Iwao H, Nakajima A, Kurose N, Sakai T, Jin ZX, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Hirose Y, Umehara H.

Int J Hematol. 2011 Jun;93(6):720-726. doi: 10.1007/s12185-011-0848-1. Epub 2011 May 15.

PMID:
21573892
48.

Severe prekallikrein deficiency due to a homozygous Trp499Stop nonsense mutation.

Nakao T, Yamane T, Katagami T, Shiota M, Izumi Y, Samori T, Hino M, Iwao H.

Blood Coagul Fibrinolysis. 2011 Jun;22(4):337-9. doi: 10.1097/MBC.0b013e3283444ddb.

PMID:
21415712
49.

Characteristic metabolism of free amino acids in cetacean plasma: cluster analysis and comparison with mice.

Miyaji K, Nagao K, Bannai M, Asakawa H, Kohyama K, Ohtsu D, Terasawa F, Ito S, Iwao H, Ohtani N, Ohta M.

PLoS One. 2010 Nov 2;5(11):e13808. doi: 10.1371/journal.pone.0013808.

50.

Generation of a rat monoclonal antibody specific for heat shock cognate protein 70.

Shiota M, Saiwai H, Mun S, Harada A, Okada S, Odawara J, Tanaka M, Iwao H, Ohkawa Y.

Hybridoma (Larchmt). 2010 Oct;29(5):453-6. doi: 10.1089/hyb.2010.0024.

PMID:
21050049

Supplemental Content

Support Center